Wave Life Sciences Ownership 2024 | Who Owns Wave Life Sciences Now?
Institutional Ownership
8.68%
Insider Ownership
16.25%
Retail Ownership
75.07%
Institutional Holders
45.00
Wave Life Sciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 14.08% | 1.20% | 18,202,009 | - | - | 90,828,025 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 5.93% | 0.73% | 7,669,361 | -18,718 | -0.24% | 38,270,111 | Jun 30, 2024 |
| BLACKROCK INC. | 5.21% | 0.00% | 6,738,735 | 363,485 | 5.70% | 33,626,286 | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 4.77% | 39.88% | 6,164,548 | -835,452 | -11.94% | 30,761,095 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.14% | 0.05% | 5,357,719 | 156,330 | 3.01% | 26,735,018 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 4.12% | 2.01% | 5,325,000 | -25,000 | -0.47% | 26,571,750 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 3.53% | 0.58% | 4,566,251 | 514,851 | 12.71% | 22,785,592 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 3.17% | 0.33% | 4,094,458 | - | - | 20,431,345 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.08% | 1.53% | 3,975,521 | 43,439 | 1.10% | 19,837,850 | Jun 30, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | 2.06% | 0.01% | 2,664,216 | -212,224 | -7.38% | 13,294,438 | Jun 30, 2024 |
| EMERALD ADVISERS, LLC | 1.93% | 0.52% | 2,493,230 | 2,493,230 | 100.00% | 12,441,218 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.87% | 0.00% | 2,417,690 | 583,600 | 31.82% | 12,064,274 | Jun 30, 2024 |
| STATE STREET CORP | 1.75% | 0.00% | 2,263,426 | 749,007 | 49.46% | 11,294,496,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.54% | 0.00% | 1,986,245 | 73,503 | 3.84% | 9,913,584 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.41% | 0.48% | 1,820,938 | 1,820,938 | 100.00% | 9,086,481 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.29% | 0.00% | 1,664,300 | 28,690 | 1.75% | 8,304,857 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.11% | 0.00% | 1,439,271 | -421,983 | -22.67% | 7,183,000 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.70% | 0.04% | 908,096 | 348,300 | 62.22% | 4,531,399 | Jun 30, 2024 |
| MORGAN STANLEY | 0.65% | 0.00% | 837,014 | -108,106 | -11.44% | 4,176,699 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.58% | 0.00% | 751,725 | -5,566 | -0.73% | 3,751,108,000 | Jun 30, 2024 |
Wave Life Sciences's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 14.08% of the company's total share outstanding, currently valued at $90.83M. The top 10 institutional shareholders own together 50.09% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| M28 CAPITAL MANAGEMENT LP | 4.77% | 39.88% | 6,164,548 | -835,452 | -11.94% | 30,761,095 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.38% | 3.84% | 496,635 | 496,635 | 100.00% | 4,406,264 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 4.12% | 2.01% | 5,325,000 | -25,000 | -0.47% | 26,571,750 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.08% | 1.53% | 3,975,521 | 43,439 | 1.10% | 19,837,850 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 14.08% | 1.20% | 18,202,009 | - | - | 90,828,025 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 5.93% | 0.73% | 7,669,361 | -18,718 | -0.24% | 38,270,111 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.38% | 0.58% | 495,471 | - | - | 2,472,400 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 3.53% | 0.58% | 4,566,251 | 514,851 | 12.71% | 22,785,592 | Jun 30, 2024 |
| EMERALD ADVISERS, LLC | 1.93% | 0.52% | 2,493,230 | 2,493,230 | 100.00% | 12,441,218 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.44% | 0.50% | 575,088 | -15,000 | -2.54% | 2,869,690 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.41% | 0.48% | 1,820,938 | 1,820,938 | 100.00% | 9,086,481 | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 0.37% | 0.45% | 475,000 | -25,000 | -5.00% | 2,370,250 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 3.17% | 0.33% | 4,094,458 | - | - | 20,431,345 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.15% | 0.31% | 200,000 | 200,000 | 100.00% | 998,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.29% | 0.22% | 375,000 | 88,415 | 30.85% | 1,871,250 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.03% | 0.18% | 40,000 | - | - | 199,600 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.14% | 0.17% | 179,359 | 179,359 | 100.00% | 895,001 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.42% | 0.11% | 537,345 | -62,810 | -10.47% | 2,681,352 | Jun 30, 2024 |
| KRAEMATON INVESTMENT ADVISORS, INC | 0.01% | 0.10% | 19,000 | -3,000 | -13.64% | 94,810 | Jun 30, 2024 |
| JAMES J. BURNS & COMPANY, LLC | 0.07% | 0.09% | 90,000 | 90,000 | 100.00% | 449,000 | Jun 30, 2024 |
The largest Wave Life Sciences shareholder by % of total assets is M28 CAPITAL MANAGEMENT LP. The company owns 6.16M shares of Wave Life Sciences (WVE), representing 39.88% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EMERALD ADVISERS, LLC | 1.93% | 0.52% | 2,493,230 | 2,493,230 | 100.00% | 12,441,218 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.41% | 0.48% | 1,820,938 | 1,820,938 | 100.00% | 9,086,481 | Jun 30, 2024 |
| STATE STREET CORP | 1.75% | 0.00% | 2,263,426 | 749,007 | 49.46% | 11,294,496,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.87% | 0.00% | 2,417,690 | 583,600 | 31.82% | 12,064,274 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 3.53% | 0.58% | 4,566,251 | 514,851 | 12.71% | 22,785,592 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.38% | 3.84% | 496,635 | 496,635 | 100.00% | 4,406,264 | Jun 30, 2024 |
| BLACKROCK INC. | 5.21% | 0.00% | 6,738,735 | 363,485 | 5.70% | 33,626,286 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.27% | 0.07% | 350,000 | 350,000 | 100.00% | 1,746,500 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.70% | 0.04% | 908,096 | 348,300 | 62.22% | 4,531,399 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.15% | 0.31% | 200,000 | 200,000 | 100.00% | 998,000 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.14% | 0.17% | 179,359 | 179,359 | 100.00% | 895,001 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.22% | 0.02% | 281,060 | 168,428 | 149.54% | 1,402,489 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.14% | 0.05% | 5,357,719 | 156,330 | 3.01% | 26,735,018 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.10% | 0.00% | 133,827 | 133,827 | 100.00% | 668,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.28% | 0.01% | 366,601 | 124,741 | 51.58% | 1,829,339 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.25% | 0.00% | 326,890 | 103,540 | 46.36% | 1,631,181 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.08% | 0.00% | 102,635 | 102,635 | 100.00% | 512,147 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.13% | 0.00% | 171,049 | 95,996 | 127.90% | 853,535 | Jun 30, 2024 |
| JAMES J. BURNS & COMPANY, LLC | 0.07% | 0.09% | 90,000 | 90,000 | 100.00% | 449,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.29% | 0.22% | 375,000 | 88,415 | 30.85% | 1,871,250 | Jun 30, 2024 |
As of Jun 30 2024, Wave Life Sciences's largest institutional buyer is EMERALD ADVISERS, LLC. The company purchased 2.49M stocks of WVE, valued at $12.44M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 0.09% | 0.00% | 115,478 | -1,859,259 | -94.15% | 576,235 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -948,444 | -100.00% | - | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 4.77% | 39.88% | 6,164,548 | -835,452 | -11.94% | 30,761,095 | Jun 30, 2024 |
| FMR LLC | 0.43% | 0.00% | 561,080 | -607,693 | -51.99% | 2,799,789 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.11% | 0.00% | 1,439,271 | -421,983 | -22.67% | 7,183,000 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.40% | 0.03% | 516,473 | -355,027 | -40.74% | 2,577,200 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.10% | 0.00% | 124,679 | -292,046 | -70.08% | 622,148 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.05% | 0.00% | 62,102 | -251,303 | -80.18% | 309,890 | Jun 30, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | 2.06% | 0.01% | 2,664,216 | -212,224 | -7.38% | 13,294,438 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.08% | 0.00% | 108,567 | -176,525 | -61.92% | 541,749 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -164,620 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 0.00% | 273,272 | -160,305 | -36.97% | 1,363,627 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.26% | 0.01% | 339,749 | -122,833 | -26.55% | 1,695,348 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | - | - | - | -113,840 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.65% | 0.00% | 837,014 | -108,106 | -11.44% | 4,176,699 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.18% | 0.00% | 234,931 | -105,747 | -31.04% | 1,172,306 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -68,538 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.14% | 0.00% | 183,946 | -68,000 | -26.99% | 917,891 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.30% | 0.00% | 392,049 | -63,762 | -13.99% | 1,956,324 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.42% | 0.11% | 537,345 | -62,810 | -10.47% | 2,681,352 | Jun 30, 2024 |
As of Jun 30 2024, Wave Life Sciences's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -1.86M shares of WVE, valued at $576.24K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EMERALD ADVISERS, LLC | 1.93% | 0.52% | 2,493,230 | 2,493,230 | 100.00% | 12,441,218 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.41% | 0.48% | 1,820,938 | 1,820,938 | 100.00% | 9,086,481 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.38% | 3.84% | 496,635 | 496,635 | 100.00% | 4,406,264 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.27% | 0.07% | 350,000 | 350,000 | 100.00% | 1,746,500 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.15% | 0.31% | 200,000 | 200,000 | 100.00% | 998,000 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.14% | 0.17% | 179,359 | 179,359 | 100.00% | 895,001 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.08% | 0.00% | 102,635 | 102,635 | 100.00% | 512,147 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.05% | 0.02% | 68,803 | 68,803 | 100.00% | 343,327 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.04% | 0.00% | 51,700 | 51,700 | 100.00% | 256,949 | Jun 30, 2024 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 0.04% | 0.00% | 45,557 | 45,557 | 100.00% | 227,329 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 41,656 | 41,656 | 100.00% | 207,863 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 37,421 | 37,421 | 100.00% | 186,731 | Jun 30, 2024 |
| GLENMEDE TRUST CO NA | 0.02% | 0.00% | 22,840 | 22,840 | 100.00% | 113,971 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.02% | 0.00% | 21,444 | 21,444 | 100.00% | 104,432 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.01% | 0.00% | 16,987 | 16,987 | 100.00% | 84,765 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.01% | - | 15,572 | 15,572 | 100.00% | 77,704 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.01% | 0.00% | 14,900 | 14,900 | 100.00% | 74,351 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.01% | - | 14,766 | 14,766 | 100.00% | 73,682,000 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.03% | 13,970 | 13,970 | 100.00% | 69,710 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.01% | 0.00% | 11,459 | 11,459 | 100.00% | 57,180 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.01% | 0.00% | 10,625 | 10,625 | 100.00% | 53,019 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 49,900 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.00% | - | 4,537 | 4,537 | 100.00% | 22,639 | Jun 30, 2024 |
| AMUNDI | 0.00% | - | 4,357 | 4,357 | 100.00% | 23,179 | Jun 30, 2024 |
| ANCORA ADVISORS, LLC | 0.00% | 0.00% | 3,000 | 3,000 | 100.00% | 14,970 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,193 | 1,193 | 100.00% | 5,953 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 300 | 300 | 100.00% | 1,497 | Jun 30, 2024 |
| ASPIRE PRIVATE CAPITAL, LLC | 0.00% | 0.00% | 150 | 150 | 100.00% | 749 | Jun 30, 2024 |
| PRINCIPAL SECURITIES, INC. | - | - | 25 | 25 | 100.00% | 125 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | 3 | 3 | 100.00% | 18 | Jun 30, 2024 |
Wave Life Sciences's largest new institutional shareholder by number of shares is EMERALD ADVISERS, LLC, purchased 2.49M shares, valued at $12.44M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | - | - | - | -948,444 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -164,620 | -100.00% | - | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | - | - | - | -113,840 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -68,538 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -59,082 | -100.00% | - | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -56,051 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -55,129 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -54,500 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -46,837 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -42,223 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -36,241 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -34,199 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -34,149 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -27,541 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -20,640 | -100.00% | - | Jun 30, 2024 |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | - | - | - | -18,559 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -8,971 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,918 | -100.00% | - | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | - | - | - | -1,100 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -493 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -12 | -100.00% | - | Jun 30, 2024 |
Wave Life Sciences's largest sold out institutional shareholder by shares sold is WOODLINE PARTNERS LP, sold -0.95M shares, valued at -, as of undefined.
Wave Life Sciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| PRIMECAP Odyssey Funds | 0.41% | 3,317,970 | 22,200 | 0.67% | Jan 31, 2024 |
| Clough Funds Trust | 0.22% | 9,200 | - | - | Jan 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,512 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,376,466 | -568,920 | -29.24% | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 13,200 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.00% | 2,000 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 48,932 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 48,432 | 27,735 | 134.00% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 25,105 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 4,595 | - | - | Mar 28, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 45,825 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 3,975 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 33,050 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 909 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 39,923 | 6,153 | 18.22% | Mar 28, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 11,271 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 259,236 | 27,909 | 12.06% | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,883 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 175,813 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 571 | 74 | 14.89% | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,587 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,745 | 4,413 | 82.76% | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 9,353 | -80 | -0.85% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 29,537 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 53,018 | 1,470 | 2.85% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 8,294 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,969 | - | - | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,097 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 1,879 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 288 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 31,495 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 29,824 | 4,621 | 18.34% | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 25,994 | 25,994 | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,328 | - | - | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 42,611 | 24,611 | 136.73% | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 860 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 20,850 | -410 | -1.93% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 68 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 94 | - | - | Jan 31, 2024 |
Wave Life Sciences's largest mutual fund holder by % of total assets is "PRIMECAP Odyssey Funds", owning 3.32M shares, compromising 0.41% of its total assets.
Wave Life Sciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 45 | -66.17% |
| 31 Mar, 24 | 133 | 12.71% |
| 31 Dec, 23 | 118 | 35.63% |
| 30 Sep, 23 | 87 | 3.57% |
| 30 Jun, 23 | 84 | 10.53% |
| 31 Mar, 23 | 76 | -3.80% |
| 31 Dec, 22 | 79 | 29.51% |
| 30 Sep, 22 | 61 | 3.39% |
| 30 Jun, 22 | 59 | -26.25% |
| 31 Mar, 22 | 80 | -17.53% |
| 31 Dec, 21 | 97 | 7.78% |
| 30 Sep, 21 | 90 | - |
| 30 Jun, 21 | 90 | -21.74% |
| 31 Mar, 21 | 115 | - |
| 31 Dec, 20 | 115 | - |
| 30 Sep, 20 | 115 | 19.79% |
| 30 Jun, 20 | 96 | 11.63% |
| 31 Mar, 20 | 86 | -23.21% |
| 31 Dec, 19 | 112 | 19.15% |
| 30 Sep, 19 | 94 | -16.07% |
| 30 Jun, 19 | 112 | -3.45% |
| 31 Mar, 19 | 116 | 26.09% |
| 31 Dec, 18 | 92 | - |
| 30 Sep, 18 | 92 | 17.95% |
| 30 Jun, 18 | 78 | -1.27% |
| 31 Mar, 18 | 79 | 9.72% |
| 31 Dec, 17 | 72 | 24.14% |
| 30 Sep, 17 | 58 | 3.57% |
| 30 Jun, 17 | 56 | 12.00% |
| 31 Mar, 17 | 50 | -1.96% |
| 31 Dec, 16 | 51 | 10.87% |
| 30 Sep, 16 | 46 | 21.05% |
| 30 Jun, 16 | 38 | 72.73% |
| 31 Mar, 16 | 22 | 15.79% |
| 31 Dec, 15 | 19 | - |
As of 30 Jun 24, 45 institutions are holding Wave Life Sciences's shares, representing a decrease of -66.17% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 11,220,540 | -87.73% |
| 31 Mar, 24 | 91,412,702 | 0.25% |
| 31 Dec, 23 | 91,181,370 | 25.54% |
| 30 Sep, 23 | 72,629,619 | 0.64% |
| 30 Jun, 23 | 72,166,045 | 2.97% |
| 31 Mar, 23 | 70,087,051 | -95.41% |
| 31 Dec, 22 | 1,527,454,603 | 2171.05% |
| 30 Sep, 22 | 67,257,588 | -0.78% |
| 30 Jun, 22 | 67,785,427 | 42.13% |
| 31 Mar, 22 | 47,692,479 | 0.77% |
| 31 Dec, 21 | 47,329,973 | 26.45% |
| 30 Sep, 21 | 37,428,869 | 1.04% |
| 30 Jun, 21 | 37,041,874 | -3.24% |
| 31 Mar, 21 | 38,282,581 | 6.05% |
| 31 Dec, 20 | 36,098,039 | -2.67% |
| 30 Sep, 20 | 37,088,458 | 26.28% |
| 30 Jun, 20 | 29,370,339 | -2.43% |
| 31 Mar, 20 | 30,100,886 | 2.04% |
| 31 Dec, 19 | 29,499,306 | -4.47% |
| 30 Sep, 19 | 30,880,200 | 1.35% |
| 30 Jun, 19 | 30,470,038 | 3.64% |
| 31 Mar, 19 | 29,400,293 | 20.53% |
| 31 Dec, 18 | 24,393,064 | 2.48% |
| 30 Sep, 18 | 23,803,154 | -2.71% |
| 30 Jun, 18 | 24,465,389 | 3.39% |
| 31 Mar, 18 | 23,663,823 | 6.47% |
| 31 Dec, 17 | 22,225,357 | 8.46% |
| 30 Sep, 17 | 20,492,602 | 6.09% |
| 30 Jun, 17 | 19,316,343 | 22.72% |
| 31 Mar, 17 | 15,739,701 | 6.19% |
| 31 Dec, 16 | 14,822,273 | 5.41% |
| 30 Sep, 16 | 14,061,154 | -0.98% |
| 30 Jun, 16 | 14,199,637 | 1.42% |
| 31 Mar, 16 | 14,000,592 | 1.54% |
| 31 Dec, 15 | 13,788,882 | - |
Wave Life Sciences (WVE) has 11.22M shares outstanding as of 30 Jun 24, down -87.73% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 8.68% | 0.12% |
| 31 Mar, 24 | 86.16% | 1.17% |
| 31 Dec, 23 | 86.00% | 1.81% |
| 30 Sep, 23 | 68.87% | 1.38% |
| 30 Jun, 23 | 70.71% | 1.50% |
| 31 Mar, 23 | 68.67% | 0.00% |
| 31 Dec, 22 | 1625.06% | 31.68% |
| 30 Sep, 22 | 71.63% | 0.69% |
| 30 Jun, 22 | 101.96% | 1.64% |
| 31 Mar, 22 | 78.81% | 0.94% |
| 31 Dec, 21 | 91.33% | 1.68% |
| 30 Sep, 21 | 73.81% | 1.34% |
| 30 Jun, 21 | 74.12% | 1.22% |
| 31 Mar, 21 | 77.97% | 1.42% |
| 31 Dec, 20 | 74.01% | 0.79% |
| 30 Sep, 20 | 96.67% | 1.39% |
| 30 Jun, 20 | 83.41% | 1.09% |
| 31 Mar, 20 | 87.35% | 1.18% |
| 31 Dec, 19 | 85.99% | 1.06% |
| 30 Sep, 19 | 90.08% | 1.14% |
| 30 Jun, 19 | 88.94% | 1.09% |
| 31 Mar, 19 | 90.19% | 1.27% |
| 31 Dec, 18 | 84.20% | 1.28% |
| 30 Sep, 18 | 81.15% | 1.15% |
| 30 Jun, 18 | 83.95% | 1.17% |
| 31 Mar, 18 | 84.76% | 1.21% |
| 31 Dec, 17 | 83.83% | 1.54% |
| 30 Sep, 17 | 73.82% | 1.43% |
| 30 Jun, 17 | 71.81% | 1.61% |
| 31 Mar, 17 | 66.89% | 1.69% |
| 31 Dec, 16 | 62.99% | 1.75% |
| 30 Sep, 16 | 59.97% | 1.53% |
| 30 Jun, 16 | 62.53% | 1.48% |
| 31 Mar, 16 | 64.96% | 1.59% |
| 31 Dec, 15 | 63.98% | - |
As of 30 Jun 24, Wave Life Sciences is held by 8.68% institutional shareholders, representing a 0.12% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 29 | -66.28% |
| 31 Mar, 24 | 86 | -1.15% |
| 31 Dec, 23 | 87 | 123.08% |
| 30 Sep, 23 | 39 | -17.02% |
| 30 Jun, 23 | 47 | 20.51% |
| 31 Mar, 23 | 39 | -25.00% |
| 31 Dec, 22 | 52 | 79.31% |
| 30 Sep, 22 | 29 | 20.83% |
| 30 Jun, 22 | 24 | -14.29% |
| 31 Mar, 22 | 28 | -50.88% |
| 31 Dec, 21 | 57 | 42.50% |
| 30 Sep, 21 | 40 | -11.11% |
| 30 Jun, 21 | 45 | -6.25% |
| 31 Mar, 21 | 48 | -17.24% |
| 31 Dec, 20 | 58 | -19.44% |
| 30 Sep, 20 | 72 | 38.46% |
| 30 Jun, 20 | 52 | 20.93% |
| 31 Mar, 20 | 43 | -21.82% |
| 31 Dec, 19 | 55 | 30.95% |
| 30 Sep, 19 | 42 | -39.13% |
| 30 Jun, 19 | 69 | -21.59% |
| 31 Mar, 19 | 88 | 83.33% |
| 31 Dec, 18 | 48 | - |
| 30 Sep, 18 | 48 | -5.88% |
| 30 Jun, 18 | 51 | 6.25% |
| 31 Mar, 18 | 48 | 23.08% |
| 31 Dec, 17 | 39 | 21.88% |
| 30 Sep, 17 | 32 | -23.81% |
| 30 Jun, 17 | 42 | 55.56% |
| 31 Mar, 17 | 27 | -12.90% |
| 31 Dec, 16 | 31 | 14.81% |
| 30 Sep, 16 | 27 | -6.90% |
| 30 Jun, 16 | 29 | 163.64% |
| 31 Mar, 16 | 11 | -42.11% |
| 31 Dec, 15 | 19 | - |
29 institutional shareholders have increased their position in WVE stock as of 30 Jun 24 compared to 86 in the previous quarter (a -66.28% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -75.76% |
| 31 Mar, 24 | 33 | 230.00% |
| 31 Dec, 23 | 10 | -64.29% |
| 30 Sep, 23 | 28 | 47.37% |
| 30 Jun, 23 | 19 | -26.92% |
| 31 Mar, 23 | 26 | 62.50% |
| 31 Dec, 22 | 16 | -5.88% |
| 30 Sep, 22 | 17 | -37.04% |
| 30 Jun, 22 | 27 | -20.59% |
| 31 Mar, 22 | 34 | 70.00% |
| 31 Dec, 21 | 20 | -25.93% |
| 30 Sep, 21 | 27 | - |
| 30 Jun, 21 | 27 | -20.59% |
| 31 Mar, 21 | 34 | 9.68% |
| 31 Dec, 20 | 31 | 6.90% |
| 30 Sep, 20 | 29 | 16.00% |
| 30 Jun, 20 | 25 | 4.17% |
| 31 Mar, 20 | 24 | -27.27% |
| 31 Dec, 19 | 33 | 3.13% |
| 30 Sep, 19 | 32 | 52.38% |
| 30 Jun, 19 | 21 | 40.00% |
| 31 Mar, 19 | 15 | -54.55% |
| 31 Dec, 18 | 33 | 22.22% |
| 30 Sep, 18 | 27 | 35.00% |
| 30 Jun, 18 | 20 | -4.76% |
| 31 Mar, 18 | 21 | -16.00% |
| 31 Dec, 17 | 25 | 108.33% |
| 30 Sep, 17 | 12 | 50.00% |
| 30 Jun, 17 | 8 | -38.46% |
| 31 Mar, 17 | 13 | 18.18% |
| 31 Dec, 16 | 11 | 10.00% |
| 30 Sep, 16 | 10 | 100.00% |
| 30 Jun, 16 | 5 | - |
| 31 Mar, 16 | 5 | - |
| 31 Dec, 15 | - | - |
8 institutional shareholders have reduced their position in WVE stock as of 30 Jun 24 compared to 33 in the previous quarter (a -75.76% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 45 | -66.17% | 11,220,540 | -87.73% | 8.68% | 0.12% | 29 | -66.28% | 8 | -75.76% |
| 31 Mar, 24 | 133 | 12.71% | 91,412,702 | 0.25% | 86.16% | 1.17% | 86 | -1.15% | 33 | 230.00% |
| 31 Dec, 23 | 118 | 35.63% | 91,181,370 | 25.54% | 86.00% | 1.81% | 87 | 123.08% | 10 | -64.29% |
| 30 Sep, 23 | 87 | 3.57% | 72,629,619 | 0.64% | 68.87% | 1.38% | 39 | -17.02% | 28 | 47.37% |
| 30 Jun, 23 | 84 | 10.53% | 72,166,045 | 2.97% | 70.71% | 1.50% | 47 | 20.51% | 19 | -26.92% |
| 31 Mar, 23 | 76 | -3.80% | 70,087,051 | -95.41% | 68.67% | 0.00% | 39 | -25.00% | 26 | 62.50% |
| 31 Dec, 22 | 79 | 29.51% | 1,527,454,603 | 2171.05% | 1625.06% | 31.68% | 52 | 79.31% | 16 | -5.88% |
| 30 Sep, 22 | 61 | 3.39% | 67,257,588 | -0.78% | 71.63% | 0.69% | 29 | 20.83% | 17 | -37.04% |
| 30 Jun, 22 | 59 | -26.25% | 67,785,427 | 42.13% | 101.96% | 1.64% | 24 | -14.29% | 27 | -20.59% |
| 31 Mar, 22 | 80 | -17.53% | 47,692,479 | 0.77% | 78.81% | 0.94% | 28 | -50.88% | 34 | 70.00% |
| 31 Dec, 21 | 97 | 7.78% | 47,329,973 | 26.45% | 91.33% | 1.68% | 57 | 42.50% | 20 | -25.93% |
| 30 Sep, 21 | 90 | - | 37,428,869 | 1.04% | 73.81% | 1.34% | 40 | -11.11% | 27 | - |
| 30 Jun, 21 | 90 | -21.74% | 37,041,874 | -3.24% | 74.12% | 1.22% | 45 | -6.25% | 27 | -20.59% |
| 31 Mar, 21 | 115 | - | 38,282,581 | 6.05% | 77.97% | 1.42% | 48 | -17.24% | 34 | 9.68% |
| 31 Dec, 20 | 115 | - | 36,098,039 | -2.67% | 74.01% | 0.79% | 58 | -19.44% | 31 | 6.90% |
| 30 Sep, 20 | 115 | 19.79% | 37,088,458 | 26.28% | 96.67% | 1.39% | 72 | 38.46% | 29 | 16.00% |
| 30 Jun, 20 | 96 | 11.63% | 29,370,339 | -2.43% | 83.41% | 1.09% | 52 | 20.93% | 25 | 4.17% |
| 31 Mar, 20 | 86 | -23.21% | 30,100,886 | 2.04% | 87.35% | 1.18% | 43 | -21.82% | 24 | -27.27% |
| 31 Dec, 19 | 112 | 19.15% | 29,499,306 | -4.47% | 85.99% | 1.06% | 55 | 30.95% | 33 | 3.13% |
| 30 Sep, 19 | 94 | -16.07% | 30,880,200 | 1.35% | 90.08% | 1.14% | 42 | -39.13% | 32 | 52.38% |
| 30 Jun, 19 | 112 | -3.45% | 30,470,038 | 3.64% | 88.94% | 1.09% | 69 | -21.59% | 21 | 40.00% |
| 31 Mar, 19 | 116 | 26.09% | 29,400,293 | 20.53% | 90.19% | 1.27% | 88 | 83.33% | 15 | -54.55% |
| 31 Dec, 18 | 92 | - | 24,393,064 | 2.48% | 84.20% | 1.28% | 48 | - | 33 | 22.22% |
| 30 Sep, 18 | 92 | 17.95% | 23,803,154 | -2.71% | 81.15% | 1.15% | 48 | -5.88% | 27 | 35.00% |
| 30 Jun, 18 | 78 | -1.27% | 24,465,389 | 3.39% | 83.95% | 1.17% | 51 | 6.25% | 20 | -4.76% |
| 31 Mar, 18 | 79 | 9.72% | 23,663,823 | 6.47% | 84.76% | 1.21% | 48 | 23.08% | 21 | -16.00% |
| 31 Dec, 17 | 72 | 24.14% | 22,225,357 | 8.46% | 83.83% | 1.54% | 39 | 21.88% | 25 | 108.33% |
| 30 Sep, 17 | 58 | 3.57% | 20,492,602 | 6.09% | 73.82% | 1.43% | 32 | -23.81% | 12 | 50.00% |
| 30 Jun, 17 | 56 | 12.00% | 19,316,343 | 22.72% | 71.81% | 1.61% | 42 | 55.56% | 8 | -38.46% |
| 31 Mar, 17 | 50 | -1.96% | 15,739,701 | 6.19% | 66.89% | 1.69% | 27 | -12.90% | 13 | 18.18% |
| 31 Dec, 16 | 51 | 10.87% | 14,822,273 | 5.41% | 62.99% | 1.75% | 31 | 14.81% | 11 | 10.00% |
| 30 Sep, 16 | 46 | 21.05% | 14,061,154 | -0.98% | 59.97% | 1.53% | 27 | -6.90% | 10 | 100.00% |
| 30 Jun, 16 | 38 | 72.73% | 14,199,637 | 1.42% | 62.53% | 1.48% | 29 | 163.64% | 5 | - |
| 31 Mar, 16 | 22 | 15.79% | 14,000,592 | 1.54% | 64.96% | 1.59% | 11 | -42.11% | 5 | - |
| 31 Dec, 15 | 19 | - | 13,788,882 | - | 63.98% | - | 19 | - | - | - |
Wave Life Sciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Wave Life Sciences's stock was made by Vargeese Chandra on Jul 24 2024, selling 68,210 shares at $2.48 per share (valued at $169.16K).
Wave Life Sciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 17 | 1 | 1700.00% |
| Q2 2024 | - | 1 | - |
| Q1 2024 | 4 | - | - |
| Q4 2023 | 3 | - | - |
| Q3 2023 | 8 | 1 | 800.00% |
| Q1 2023 | 4 | 4 | 100.00% |
| Q4 2022 | 1 | - | - |
| Q3 2022 | 23 | - | - |
| Q2 2022 | 8 | 5 | 160.00% |
| Q1 2022 | 5 | 5 | 100.00% |
| Q3 2021 | 8 | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 11 | 6 | 183.33% |
| Q4 2020 | - | 5 | - |
| Q3 2020 | 12 | 9 | 133.33% |
| Q1 2020 | 5 | 7 | 71.43% |
| Q4 2019 | 1 | 5 | 20.00% |
| Q3 2019 | 12 | 2 | 600.00% |
| Q1 2019 | 7 | 12 | 58.33% |
| Q4 2018 | - | 2 | - |
17 total buy trades, and 1 total sell trades (buy/sell ratio of 17.00%) were made by Wave Life Sciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 3 | - | - |
| Q3 2023 | - | 1 | - |
| Q1 2023 | - | 4 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 3 | 5 | 60.00% |
| Q1 2022 | - | 5 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 5 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | 6 | - |
| Q1 2020 | - | 5 | - |
| Q4 2019 | - | 4 | - |
| Q3 2019 | - | 2 | - |
| Q1 2019 | 1 | 11 | 9.09% |
| Q4 2018 | - | 2 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Wave Life Sciences's stocks.
Wave Life Sciences Peer Ownership
| Ticker | Company |
|---|---|
| ARWR | Arrowhead Pharmaceuticals, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| VECT | VectivBio Holding AG |
| MREO | Mereo BioPharma Group plc |
| APLS | Apellis Pharmaceuticals, Inc. |
| TCRX | TScan Therapeutics, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| ALNY | Alnylam Pharmaceuticals, Inc. |
| PRQR | ProQR Therapeutics N.V. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| ITOS | iTeos Therapeutics, Inc. |
| NLTX | Neurogene Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
WVE Ownership FAQ
Who Owns Wave Life Sciences?
Wave Life Sciences is owned by institutional shareholders (8.68%), insiders (16.25%), and public (75.07%). The largest institutional shareholder of Wave Life Sciences is RA CAPITAL MANAGEMENT, L.P. (14.08% of total shares) and the top mutual fund owner is PRIMECAP Odyssey Funds (0.41% of total shares).
Who are the major institutional shareholders of Wave Life Sciences?
Wave Life Sciences's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., MAVERICK CAPITAL LTD, BLACKROCK INC., M28 CAPITAL MANAGEMENT LP, and ADAGE CAPITAL PARTNERS GP, L.L.C.. The top five shareholders own together 34.14% of the company's share outstanding.
How many Wave Life Sciences shareholders are there?
As of Jun 2024, there are 45 institutional shareholders of Wave Life Sciences.
What percentage of Wave Life Sciences is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 18.2M shares of Wave Life Sciences, representing 14.08% of the company's total shares outstanding, valued at $90.83M (as of Jun 2024).
What percentage of Wave Life Sciences is owned by MAVERICK CAPITAL LTD?
As of Jun 2024, MAVERICK CAPITAL LTD holds 7.67M shares of Wave Life Sciences (WVE), compromising 5.93% of the company, valued at $38.27M.
What percentage of Wave Life Sciences is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Wave Life Sciences. The company owns 6.74M of the company's shares outstanding (worth $33.63M).